OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Impact of Immune Parameters and Immune Dysfunctions on the Prognosis of Patients with Chronic Lymphocytic Leukemia
Candida Vitale, Elia Boccellato, Lorenzo Comba, et al.
Cancers (2021) Vol. 13, Iss. 15, pp. 3856-3856
Open Access | Times Cited: 16
Candida Vitale, Elia Boccellato, Lorenzo Comba, et al.
Cancers (2021) Vol. 13, Iss. 15, pp. 3856-3856
Open Access | Times Cited: 16
Showing 16 citing articles:
Prediction of severe infections in chronic lymphocytic leukemia: a simple risk score to stratify patients at diagnosis
Roberta Murru, Andrea Galitzia, Luca Barabino, et al.
Annals of Hematology (2024) Vol. 103, Iss. 5, pp. 1655-1664
Open Access | Times Cited: 6
Roberta Murru, Andrea Galitzia, Luca Barabino, et al.
Annals of Hematology (2024) Vol. 103, Iss. 5, pp. 1655-1664
Open Access | Times Cited: 6
Chronic Lymphocytic Leukemia
Min Shi, Dragan Jevremović, Curtis A. Hanson, et al.
(2024), pp. 1193-1205
Closed Access | Times Cited: 5
Min Shi, Dragan Jevremović, Curtis A. Hanson, et al.
(2024), pp. 1193-1205
Closed Access | Times Cited: 5
A Ferroptosis Molecular Subtype-Related Signature for Predicting Prognosis and Response to Chemotherapy in Patients with Chronic Lymphocytic Leukemia
Han Gong, Heng Li, Qin Yang, et al.
BioMed Research International (2022) Vol. 2022, pp. 1-24
Open Access | Times Cited: 13
Han Gong, Heng Li, Qin Yang, et al.
BioMed Research International (2022) Vol. 2022, pp. 1-24
Open Access | Times Cited: 13
Chronic Lymphocytic Leukemia: Management of Adverse Events in the Era of Targeted Agents
Andrea Galitzia, Monica Maccaferri, Francesca Romana Mauro, et al.
Cancers (2024) Vol. 16, Iss. 11, pp. 1996-1996
Open Access | Times Cited: 2
Andrea Galitzia, Monica Maccaferri, Francesca Romana Mauro, et al.
Cancers (2024) Vol. 16, Iss. 11, pp. 1996-1996
Open Access | Times Cited: 2
CAR-modified Cellular Therapies in Chronic Lymphocytic Leukemia: Is the Uphill Road Getting Less Steep?
Candida Vitale, Valentina Griggio, Francesca Perutelli, et al.
HemaSphere (2023) Vol. 7, Iss. 12, pp. e988-e988
Open Access | Times Cited: 6
Candida Vitale, Valentina Griggio, Francesca Perutelli, et al.
HemaSphere (2023) Vol. 7, Iss. 12, pp. e988-e988
Open Access | Times Cited: 6
Unravelling soluble immune checkpoints in chronic lymphocytic leukemia: Physiological immunomodulators or immune dysfunction
Alicia Landeira‐Viñuela, Carlota Arias‐Hidalgo, Pablo Juanes‐Velasco, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 10
Alicia Landeira‐Viñuela, Carlota Arias‐Hidalgo, Pablo Juanes‐Velasco, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 10
Complex evaluation of serum immunoglobulin levels in patients with chronic lymphocytic leukemia: Significant increase in IgA after first‐line chemoimmunotherapy
Pavel Vodárek, Dominika Écsiová, V. Řezáčová, et al.
Cancer Medicine (2024) Vol. 13, Iss. 15
Open Access | Times Cited: 1
Pavel Vodárek, Dominika Écsiová, V. Řezáčová, et al.
Cancer Medicine (2024) Vol. 13, Iss. 15
Open Access | Times Cited: 1
Outcomes of COVID-19 infection in patients with chronic lymphocytic leukemia: a systematic review and meta-analysis
Mohammad Amin Akbarzadeh, Yosra Vaez-Gharamaleki, Farid Jahanshahlou, et al.
Revista da Associação Médica Brasileira (2024) Vol. 70, Iss. 8
Open Access | Times Cited: 1
Mohammad Amin Akbarzadeh, Yosra Vaez-Gharamaleki, Farid Jahanshahlou, et al.
Revista da Associação Médica Brasileira (2024) Vol. 70, Iss. 8
Open Access | Times Cited: 1
Systematic Evaluation of Antigenic Stimulation in Chronic Lymphocytic Leukemia: Humoral Immunity as Biomarkers for Disease Evolution
Alicia Landeira‐Viñuela, Miguel Alcoceba, Almudena Navarro‐Bailón, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 891-891
Open Access | Times Cited: 1
Alicia Landeira‐Viñuela, Miguel Alcoceba, Almudena Navarro‐Bailón, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 891-891
Open Access | Times Cited: 1
Immune Dysfunction and Infection – Interaction between CLL and Treatment: A Reflection on Current Treatment Paradigms and Unmet Needs
Ernesto Gargiulo, Rebecca Svanberg Teglgaard, Tereza Faitová, et al.
Acta Haematologica (2023) Vol. 147, Iss. 1, pp. 84-98
Open Access | Times Cited: 1
Ernesto Gargiulo, Rebecca Svanberg Teglgaard, Tereza Faitová, et al.
Acta Haematologica (2023) Vol. 147, Iss. 1, pp. 84-98
Open Access | Times Cited: 1
Spontaneous Regression Accompanied by Concomitant Immune Alterations in a Patient with Chronic Lymphocytic Leukemia
Gonzalo Blanco, Edward P. Morris, Jodie L. Morris, et al.
Annals of Case Reports (2024) Vol. 9, Iss. 1
Open Access
Gonzalo Blanco, Edward P. Morris, Jodie L. Morris, et al.
Annals of Case Reports (2024) Vol. 9, Iss. 1
Open Access
Management of infections for patient treated with ibrutinib in clinical practice
Claudia Baratè, Ilaria Scortechini, Sara Ciofini, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Claudia Baratè, Ilaria Scortechini, Sara Ciofini, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Targeted Treatment of Chronic Lymphocytic Leukemia: Clinical Utility of Acalabrutinib
Candida Vitale, Jamie Gibbons, Alessandra Ferrajoli
OncoTargets and Therapy (2021) Vol. Volume 14, pp. 5507-5519
Open Access | Times Cited: 3
Candida Vitale, Jamie Gibbons, Alessandra Ferrajoli
OncoTargets and Therapy (2021) Vol. Volume 14, pp. 5507-5519
Open Access | Times Cited: 3
La leucémie lymphoïde chronique
Martin Gauthier
La Revue de Médecine Interne (2022) Vol. 43, Iss. 6, pp. 356-364
Closed Access | Times Cited: 1
Martin Gauthier
La Revue de Médecine Interne (2022) Vol. 43, Iss. 6, pp. 356-364
Closed Access | Times Cited: 1
Mass cytometry analysis reveals attrition of naïve and anergized self-reactive non-malignant B cells in chronic lymphocytic leukemia patients
Thibault Andrieu, Paul Mondière, P Jouve, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 1
Thibault Andrieu, Paul Mondière, P Jouve, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 1
Demyelinating Polyradiculoneuropathy in Chronic Lymphocytic Leukemia: A Case Report on BTKis versus Venetoclax-Rituximab
Alessandro Cellini, Andrea Visentin, Alessandro Salvalaggio, et al.
Hemato (2023) Vol. 5, Iss. 1, pp. 19-25
Open Access
Alessandro Cellini, Andrea Visentin, Alessandro Salvalaggio, et al.
Hemato (2023) Vol. 5, Iss. 1, pp. 19-25
Open Access
